dihydroergocryptine has been researched along with cabergoline in 3 studies
Studies (dihydroergocryptine) | Trials (dihydroergocryptine) | Recent Studies (post-2010) (dihydroergocryptine) | Studies (cabergoline) | Trials (cabergoline) | Recent Studies (post-2010) (cabergoline) |
---|---|---|---|---|---|
21 | 8 | 2 | 1,259 | 196 | 566 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Bernard, N; Descotes, J; Gillet, A; Gouraud, A; Mirkou, A; Suchovsky, D; Vial, T | 1 |
Castillo-Huerta, E; Garibay-Valencia, M; Mirabent-González, F | 1 |
1 review(s) available for dihydroergocryptine and cabergoline
Article | Year |
---|---|
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
1 trial(s) available for dihydroergocryptine and cabergoline
Article | Year |
---|---|
[Clinical comparision of alpha dihydroergocryptine against cabergoline in the treatment of the fibrocystic mastopathy].
Topics: Adolescent; Adult; Cabergoline; Dihydroergocryptine; Ergolines; Female; Fibrocystic Breast Disease; Galactorrhea; Gastrointestinal Diseases; Headache; Humans; Mastodynia; Middle Aged; Prolactin; Prospective Studies; Treatment Outcome; Young Adult | 2013 |
1 other study(ies) available for dihydroergocryptine and cabergoline
Article | Year |
---|---|
[Prescription of ergot derivatives for lactation inhibition in France: Current practices].
Topics: Bromocriptine; Cabergoline; Dihydroergocryptine; Dopamine Agonists; Ergolines; Ergot Alkaloids; Female; France; Humans; Lactation; Lisuride; Practice Patterns, Physicians'; Prolactin; Surveys and Questionnaires | 2012 |